Keywords: biovail, tiazac, xc, cleared, canada, canadian, company
Biovail's Tiazac XC cleared in Canada
Article | 23 August 2004
Canadian company Biovail Corp says that Canada's Therapeutic ProductsDirectorate has granted marketing authorization for its Tiazac XC (diltiazem hydrochloride) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
